Trellus Health (UK) Performance
| TRLS Stock | 0.68 0.02 2.86% |
The entity has a beta of -1.24, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Trellus Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Trellus Health is expected to outperform it. At this point, Trellus Health plc has a negative expected return of -0.55%. Please make sure to validate Trellus Health's total risk alpha, maximum drawdown, and the relationship between the jensen alpha and treynor ratio , to decide if Trellus Health plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Trellus Health plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Trellus Health plc Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com | 09/25/2024 |
| Begin Period Cash Flow | 19.1 M |
Trellus |
Trellus Health Relative Risk vs. Return Landscape
If you would invest 110.00 in Trellus Health plc on August 28, 2024 and sell it today you would lose (42.00) from holding Trellus Health plc or give up 38.18% of portfolio value over 90 days. Trellus Health plc is generating negative expected returns and assumes 6.1802% volatility on return distribution over the 90 days horizon. Simply put, 55% of stocks are less volatile than Trellus, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Trellus Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trellus Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Trellus Health plc, and traders can use it to determine the average amount a Trellus Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0897
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRLS |
Estimated Market Risk
| 6.18 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.55 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Trellus Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trellus Health by adding Trellus Health to a well-diversified portfolio.
Trellus Health Fundamentals Growth
Trellus Stock prices reflect investors' perceptions of the future prospects and financial health of Trellus Health, and Trellus Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Trellus Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (81.08) % | ||||
| Current Valuation | (5.3 M) | ||||
| Shares Outstanding | 161.51 M | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 19.82 X | ||||
| Revenue | 19 K | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (5.85 M) | ||||
| Net Income | (6.8 M) | ||||
| Total Debt | 786 K | ||||
| Book Value Per Share | 0.1 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 20.29 M | ||||
| Retained Earnings | (21.81 M) | ||||
About Trellus Health Performance
Assessing Trellus Health's fundamental ratios provides investors with valuable insights into Trellus Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Trellus Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Trellus Health is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Trellus Health plc performance evaluation
Checking the ongoing alerts about Trellus Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Trellus Health plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Trellus Health plc generated a negative expected return over the last 90 days | |
| Trellus Health plc has high historical volatility and very poor performance | |
| Trellus Health plc has some characteristics of a very speculative penny stock | |
| Trellus Health plc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 19 K. Net Loss for the year was (6.8 M) with profit before overhead, payroll, taxes, and interest of 25 K. | |
| Trellus Health generates negative cash flow from operations | |
| About 47.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Trellus Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Trellus Health's stock is overvalued or undervalued compared to its peers.
- Examining Trellus Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Trellus Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Trellus Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Trellus Health's stock. These opinions can provide insight into Trellus Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Trellus Stock Analysis
When running Trellus Health's price analysis, check to measure Trellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trellus Health is operating at the current time. Most of Trellus Health's value examination focuses on studying past and present price action to predict the probability of Trellus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trellus Health's price. Additionally, you may evaluate how the addition of Trellus Health to your portfolios can decrease your overall portfolio volatility.